Pfizer, Bayer, Boehringer Clot-Busting Drugs May Reap Billons
Dec. 10 (Bloomberg) — The first new drugs in 60 years to
prevent vein-clogging clots are emerging from research
laboratories and may bring billions of dollars in sales to
Johnson & Johnson, Bayer AG and Boehringer Ingelheim GmbH.
The new blood-thinning medicines are designed mainly as
alternatives to warfarin, a widely prescribed 60-year-old pill
that prevents blood clots in heart-attack Read the rest of this entry »

WASHINGTON (AP) — Far too many Americans are dying of dangerous blood clots that can masquerade as simple leg pain, says a major new government effort to get both patients and their doctors to recognize the emergency in time.
“It’s a silent killer. It’s hard to diagnose,” said acting Surgeon General Dr. Steven Galson, who announced the new campaign Monday. “I don’t think most people understand that this is a serious medical problem or what Read the rest of this entry »

MONDAY, Sept. 15 (HealthDay News) — Migraine patients face a higher risk for developing a blood clot in their veins, a team of Austrian and Italian researchers reports.
Prior studies have suggested that the absolute risk for a resulting stroke among migraine patients is actually quite low, but the current work turns conventional wisdom on its head by suggesting that a migraine diagnosis raises the risk for such potentially fatal clotting incidents Read the rest of this entry »